Evolving Management Strategies for Nonalcoholic Fatty Liver Disease-Targeting Primary Care Physicians

Diabetes Technol Ther. 2019 Nov;21(11):611-618. doi: 10.1089/dia.2019.0158. Epub 2019 Jul 29.
No abstract available

MeSH terms

  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Biomarkers / blood
  • Comorbidity
  • Diagnostic Imaging
  • Disease Progression
  • Early Diagnosis
  • Female
  • Fibrosis / diagnosis*
  • Fibrosis / therapy
  • Health Services Research
  • Humans
  • Liver / pathology*
  • Liver Cirrhosis / diagnosis*
  • Liver Cirrhosis / therapy
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / blood
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Physicians, Primary Care* / education
  • Practice Guidelines as Topic

Substances

  • Biomarkers
  • Aspartate Aminotransferases
  • Alanine Transaminase